Skip to content

To study the role of FDG PET-CT in patients with lower back spinal pain for localization of active site generating pain and causing pain symptoms.

To evaluate the role of 18F FDG PET-CT for detection of nociceptive metabolic activity in patients with low backache.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/046021
Enrollment
20
Registered
2022-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M545- Low back pain

Interventions

Intervention1: NIL: Nil

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Participants between the age of 18 and 75. 2) The ability to give written informed consent. 3) Ongoing pain that averaged at least 4, on a 0-10 pain scale( visual analogue scale); during a typical week, and present at least 50 percent of days during a typical week. 4) On a stable pain treatment. 5) Medical records confirming the diagnosis of low back pain.

Exclusion criteria

Exclusion criteria: 1) Breastfeeding or pregnancy. 2) blood glucose level > 150mg/dl. 3) Inability to provide consent. 4) Any suspected spine infection. 5) Any known osseous metastatic or other osseous malignancy. 6) History of major spine trauma or spinal surgery within six months from the time of scanning. 7) Any interventional pain procedures within six weeks before scanning procedure or at any point during study enrollment. 8) Past or current history of major psychiatric ilness e.g anxiety, claustrophobia, etc.

Design outcomes

Primary

MeasureTime frame
In this study, localization of the potential pain generators(nociceptor) in patients presenting with low backache with 18F FDG PET-CT.Timepoint: Diagnostic accuracies of parameters(visual analysis ,leision to bone uptake ratio and leision to blood pool uptake ratio) will be assessed on the basis of the area under the receiver operating characteristic (ROC)curve (AUC)values. In outcome, co-relation of tracer(18F FDG) uptake value (SUVmax) with pain score on VAS (visual analogue scale) with value ranging 0 to 10 and will be assessed at baseline.

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactOmeetinder singh

Post Graduate Institute of Medical Education and Research, Chandigarh

drkanojia_rajendra@yahoo.co.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026